Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. - Wikidata - awgldk - TriplyDB

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

http://www.wikidata.org/entity/Q43626458

about

Beta-blockers for hypertension Beta-blockers for hypertension Calcium channel blockers versus other classes of drugs for hypertension Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks Diuretics: again the first step in the treatment of most patients with hypertension Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity Strategies for Controlling Blood Pressure and Reducing Cardiovascular Disease Risk in Patients with Chronic Kidney Disease Interdisciplinary care clinics in chronic kidney disease Vitamin D and cardiovascular disease: potential role in health disparities Calcium channel blockers Addressing the global burden of chronic kidney disease through clinical and translational research Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions.Renal autoregulation in health and disease Association of a CYP4A11 variant and blood pressure in black men Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.Beta-blockers for hypertension.Investigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy.Testing the trajectory difference in a semi-parametric longitudinal model.Why not prescribe the best drugs for hypertension now?Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults.The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004.The role of anemia management in improving outcomes for African-Americans with chronic kidney disease CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease African American hypertensive nephropathy maps to a new locus on chromosome 9q31-q32.Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact.Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease.Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis.African Americans, hypertension and the renin angiotensin system Population based screening for chronic kidney disease: cost effectiveness study.Common charge-shift mutation Glu65Lys in K+ channel β₁-Subunit KCNMB1: pleiotropic consequences for glomerular filtration rate and progressive renal disease The impact of obstructive sleep apnea on chronic kidney disease.Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?Angiotensin-converting enzyme inhibitors will help in improving stroke outcome if given immediately after stroke Appropriate use of calcium antagonists in hypertension.The urgent call of albuminuria/proteinuria. Heeding its significance in early detection of kidney disease.Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease.

P2860

Q24201511-B2ED5A83-CB13-489C-A5EC-FDB79681D7DA Q24202812-1EB6E568-AEC3-4661-A22D-FA74B0867371 Q24236584-1D5A9A5E-399E-4945-A246-9D1E2B016672 Q24245198-D4DBA92E-1A96-4C6A-B73F-8F53896D5CA7 Q24806951-74704CDA-7BDF-45FC-A230-30FCBFE8649C Q26749491-06158980-6AD7-4D30-87E8-2A63ABC1CE1D Q26775393-C52D2C18-86A4-4F09-B5EE-4508C9073B45 Q26784077-FB89304F-F113-4D54-8CAC-31B917F8B79B Q26991916-6BC25161-B236-4352-BAAE-900C5CFA77FA Q27003120-6DB87C18-0693-4F4A-B443-B7F647B6E9F2 Q27014158-8021CF50-45B1-40C6-8BF1-2B6CEFEA76A1 Q27687254-8FA6E660-F8DF-4C40-B51C-FACDFC230C20 Q28082365-5F2D3C93-BCEB-45A0-B941-B7E73CCE946D Q28274987-FBF38A7E-2E2D-44B9-B9F7-BEF5F924F21D Q28606687-84F3D109-4725-4B34-B4E1-DEE251003534 Q30234618-F11392F9-A390-4AE4-8F39-088CB442E8E9 Q30238911-281BAB04-9F1B-411C-9450-BFA748608120 Q30245541-A4943337-151D-4EAC-9135-8717167C5538 Q30299953-C0926EAD-BEE3-4E80-A164-5E4B574422FA Q30333019-2E36F539-8C19-46FD-AE2B-AE8EE82999FD Q30407860-4836D819-810D-4E96-AC45-6460E4BFFB03 Q30585651-76E2F67F-F510-4882-B6FE-1EE9980FE589 Q33325660-DC67B619-FCBF-42AE-9F34-19A33339E0B2 Q33638261-DD903E27-8CFB-4F82-B2EB-FBC1B90BE66E Q33646679-88E0CE07-D6A5-45A0-AAD3-09017D8838E9 Q33785147-A3296405-E15A-4F5A-9BE6-D677198318E7 Q33905257-C680C849-5CA5-48DD-8CF7-FD2EF83B604C Q33973864-EC09E1AA-2FB1-4A10-B798-69DE0CDAD41F Q34038082-418395DC-B496-4296-8677-8E135712DFC6 Q34076439-2CFF20EA-60A0-4612-9317-9702CD50D5EC Q34124206-7C974E6F-E261-4CEA-AFDA-066A2EBADF90 Q34251854-5C58F5E2-A631-4FBD-9286-25B41F2FFE02 Q34286311-69F745C5-7BB4-4B00-9170-A6F317FC9A4E Q34287908-7B7AD251-EDED-442F-9762-F1C478DC2E93 Q34288892-B2B4670F-F085-45AE-ACCC-37B92CC920ED Q34306932-753745E9-B5EF-42AB-A83D-BD99A4B2112A Q34311942-1631DDBF-3D16-439B-8C71-43B8E088C85C Q34375330-E7E89E02-5D32-4AB9-AC8A-C26BB1129299 Q34417448-AEE6EA17-6A1E-4AF5-B45F-B5603D8302F9 Q34457182-95F931C6-09DF-4BCD-8612-873FC096C685

P2860

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

http://www.wikidata.org/entity/Q43626458

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Effect of ramipril vs amlodipi ...... a randomized controlled trial.

@en

Effect of ramipril vs amlodipi ...... a randomized controlled trial.

@nl

type

label

Effect of ramipril vs amlodipi ...... a randomized controlled trial.

@en

Effect of ramipril vs amlodipi ...... a randomized controlled trial.

@nl

prefLabel

Effect of ramipril vs amlodipi ...... a randomized controlled trial.

@en

Effect of ramipril vs amlodipi ...... a randomized controlled trial.

@nl

P1433

Q43626458-5EBC29FD-FB5A-4DE2-B197-070BA74A16D1

P1476

Q43626458-CF0C4D51-B145-432E-AC57-97C2D88FB100

P2093

Q43626458-11EBC7DB-783A-428A-9961-88568D50F1D5

Q43626458-11EDEC6A-3348-4B22-97DB-CAFCBFDA8DAE

Q43626458-127DA7BB-2493-470E-BA92-2C332B3BC811

Q43626458-1B7DD586-E9F5-405E-AF99-EFEBCC83717D

Q43626458-2311D31B-E88C-4A96-A6CF-02AC69EAA1E7

Q43626458-293078FF-3A12-4B30-B9C7-E3F15A4CFE22

Q43626458-3382F2BD-4985-4267-A80E-DB9041EC4176

Q43626458-39D947C7-2D80-424F-AC9B-6266A4C62B98

Q43626458-41EE4A98-E268-4495-ADCA-85ACC2326C8B

Q43626458-44F45D40-F70C-46CC-8ECB-5D7482CB8E4E

P304

Q43626458-A010E82B-7ECA-41B8-B210-059DEE355EE5

P31

Q43626458-A2174DD3-EB4B-49D0-9FF3-774442C7DA6B

P356

Q43626458-FF1C6EB6-7C55-4E1B-81B7-F37550801116

P407

Q43626458-573739A1-2779-439C-9AA7-D7950BCAC3C9

P433

Q43626458-047FF7D3-0C2C-44F8-A462-9EE6267B3584

P478

Q43626458-FFE0535A-321C-452E-9ECA-6A66A3D9CD1E

P577

Q43626458-A01DAD65-3804-4E4C-A197-95FE4F9EC5FA

P5875

Q43626458-2F18D6FE-D2C1-4F8B-9471-BBF8FFA38776

P698

Q43626458-B628A652-2EE2-4BD6-AB22-B2DD1A76E083

P921

Q43626458-85B045BE-2E8B-4081-91F2-4638294B89BC

P356

JAMA.285.21.2719

P1433

Journal of the American Medical Association

P1476

Effect of ramipril vs amlodipi ...... a randomized controlled trial.

@en

P2093

A Gabriel

http://www.w3.org/2001/XMLSchema#string

A Ojo

http://www.w3.org/2001/XMLSchema#string

African American Study of Kidney Disease and Hypertension (AASK) Study Group

http://www.w3.org/2001/XMLSchema#string

C C Tisher

http://www.w3.org/2001/XMLSchema#string

C J Johnson

http://www.w3.org/2001/XMLSchema#string

D Cheek

http://www.w3.org/2001/XMLSchema#string

D Dowie

http://www.w3.org/2001/XMLSchema#string

D O'Connor

http://www.w3.org/2001/XMLSchema#string

D Thornley-Brown

http://www.w3.org/2001/XMLSchema#string

E R Miller

http://www.w3.org/2001/XMLSchema#string

P304

2719-2728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.285.21.2719

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11952152

http://www.w3.org/2001/XMLSchema#string

P698

11386927

http://www.w3.org/2001/XMLSchema#string

P921

nephrosclerosis